ZA883239B - A multi-layer pharmaceutical composition - Google Patents

A multi-layer pharmaceutical composition

Info

Publication number
ZA883239B
ZA883239B ZA883239A ZA883239A ZA883239B ZA 883239 B ZA883239 B ZA 883239B ZA 883239 A ZA883239 A ZA 883239A ZA 883239 A ZA883239 A ZA 883239A ZA 883239 B ZA883239 B ZA 883239B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
layer pharmaceutical
layer
composition
pharmaceutical
Prior art date
Application number
ZA883239A
Other languages
English (en)
Inventor
Esko Marttila
Marttila Esko
Ilkka Larma
Larma Ilkka
Kari Vahervuo
Vahervuo Kari
Jaakko Uotila
Uotila Jaakko
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of ZA883239B publication Critical patent/ZA883239B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA883239A 1987-05-08 1988-05-05 A multi-layer pharmaceutical composition ZA883239B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI872051A FI77573C (fi) 1987-05-08 1987-05-08 Ny konsistens.

Publications (1)

Publication Number Publication Date
ZA883239B true ZA883239B (en) 1989-07-26

Family

ID=8524451

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA883239A ZA883239B (en) 1987-05-08 1988-05-05 A multi-layer pharmaceutical composition

Country Status (35)

Country Link
US (1) US4935247A (pt)
JP (1) JPS63287720A (pt)
KR (1) KR880013551A (pt)
AT (1) AT396329B (pt)
AU (1) AU610161B2 (pt)
BE (1) BE1000785A3 (pt)
CH (1) CH675070A5 (pt)
CS (1) CS270588B2 (pt)
DD (1) DD284600A5 (pt)
DE (1) DE3815562A1 (pt)
DK (1) DK247588A (pt)
EG (1) EG18603A (pt)
ES (1) ES2006649A6 (pt)
FI (1) FI77573C (pt)
FR (1) FR2630912B1 (pt)
GB (1) GB2204241B (pt)
GR (1) GR1000303B (pt)
HU (1) HU198621B (pt)
IL (1) IL86313A (pt)
IS (1) IS3339A7 (pt)
IT (1) IT1219691B (pt)
LU (1) LU87208A1 (pt)
MA (1) MA21264A1 (pt)
MX (1) MX167185B (pt)
NL (1) NL8801185A (pt)
NO (1) NO881993L (pt)
NZ (1) NZ224529A (pt)
PH (1) PH24652A (pt)
PL (1) PL272295A1 (pt)
PT (1) PT87429B (pt)
RO (1) RO101402B (pt)
RU (1) RU1836082C (pt)
SE (1) SE8801732L (pt)
YU (1) YU46457B (pt)
ZA (1) ZA883239B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01299226A (ja) * 1988-05-27 1989-12-04 Seikagaku Kogyo Co Ltd サラゾスルファピリジン腸溶顆粒
NO882653D0 (no) * 1988-06-15 1988-06-15 Apothekernes Lab Doseringsform.
US5296236A (en) * 1988-09-16 1994-03-22 Recordati S.A., Chemical And Pharmaceutical Company Controlled release therapeutic system for a liquid pharmaceutical formulations
EP0376331A3 (en) * 1988-12-29 1991-03-13 Asahi Kogaku Kogyo Kabushiki Kaisha Slow release drug delivery granules and process for production thereof
US5093128A (en) * 1989-07-18 1992-03-03 Draguesku Oliver J Rumen and other stomach chamber bypass nutrients and methods of fabrication
JP3078859B2 (ja) * 1990-02-23 2000-08-21 武田薬品工業株式会社 安定な放出制御性製剤用コーティング剤
US5084287A (en) * 1990-03-15 1992-01-28 Warner-Lambert Company Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
GB9201639D0 (en) * 1992-01-25 1992-03-11 Smithkline Beecham Plc Pharmaceutical formulations
EP0689840A1 (de) * 1994-06-28 1996-01-03 Spirig Ag Pharmazeutische Präparate Neues orales Erythromycinbase enthaltendes Arzneimittel
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US6242019B1 (en) 1997-08-14 2001-06-05 Warner-Lambert Company Taste modified hard confectionery compositions containing functional ingredients
FR2821745B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Granules et granules enrobes au gout masque
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
US8168170B2 (en) * 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
US20050152884A1 (en) * 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8877178B2 (en) * 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
JP4938006B2 (ja) * 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティク・ビフィドバクテリア
JP4938005B2 (ja) * 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティックであるラクトバシラス
WO2008093303A2 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE835500C (de) * 1950-05-18 1952-03-31 Otto Doerr Dipl Ing Verfahren zum Konservieren eines in einem indifferenten Koerper gespeicherten, im Darm zur Wirkung zu bringenden Mittels
US2828206A (en) * 1954-02-24 1958-03-25 Roseuberg Adolf Stabilized fat-soluble vitamins and methods of making same
US2963402A (en) * 1955-01-18 1960-12-06 Nysco Lab Inc Sustained release medicament
GB821790A (en) * 1956-11-20 1959-10-14 Smith Kline French Lab Method of preparing sustained release particles and the product of the method
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
NL122039C (pt) * 1960-10-20
NL297088A (pt) * 1961-01-31
BE640616A (pt) * 1962-12-19
US3256153A (en) * 1963-02-08 1966-06-14 Smith Kline French Lab Method of stabilizing wax-fat coating materials and product thereof
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
IT1148784B (it) * 1980-04-09 1986-12-03 Eurand Spa Procedimento per la preparazione di microcapsule in un veicolo liquido
NZ210785A (en) * 1984-01-13 1987-11-27 Battelle Development Corp Liquid dispersions of layered controlled release dosage forms
US4650665A (en) * 1985-02-08 1987-03-17 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
DE3750369T2 (de) * 1986-03-21 1995-05-24 Eurasiam Lab Arzneimittelzusammensetzungen.

Also Published As

Publication number Publication date
DE3815562A1 (de) 1988-11-24
AU1567288A (en) 1988-11-10
FI77573B (fi) 1988-12-30
FI872051A (fi) 1988-11-09
MX167185B (es) 1993-03-09
AU610161B2 (en) 1991-05-16
PT87429A (pt) 1989-05-31
IS3339A7 (is) 1988-08-31
NZ224529A (en) 1990-02-26
ATA119188A (de) 1992-12-15
IL86313A (en) 1991-08-16
HUT48458A (en) 1989-06-28
HU198621B (en) 1989-11-28
CS270588B2 (en) 1990-07-12
DD284600A5 (de) 1990-11-21
RO101402B (ro) 1992-01-13
SE8801732D0 (sv) 1988-05-06
BE1000785A3 (fr) 1989-04-04
PT87429B (pt) 1992-09-30
DK247588A (da) 1988-11-09
JPS63287720A (ja) 1988-11-24
FR2630912A1 (fr) 1989-11-10
CS310288A2 (en) 1989-11-14
FR2630912B1 (fr) 1991-04-12
MA21264A1 (fr) 1988-12-31
PL272295A1 (en) 1989-11-13
EG18603A (en) 1993-06-30
DK247588D0 (da) 1988-05-06
FI77573C (fi) 1989-04-10
NO881993D0 (no) 1988-05-06
YU46457B (sh) 1993-10-20
PH24652A (en) 1990-09-07
YU83188A (en) 1989-12-31
IT8820479A0 (it) 1988-05-06
SE8801732L (sv) 1988-11-09
GB2204241A (en) 1988-11-09
GB2204241B (en) 1991-02-20
GB8810765D0 (en) 1988-06-08
GR880100297A (en) 1989-02-23
FI872051A0 (fi) 1987-05-08
RU1836082C (ru) 1993-08-23
IT1219691B (it) 1990-05-24
IL86313A0 (en) 1988-11-15
NO881993L (no) 1988-11-09
US4935247A (en) 1990-06-19
AT396329B (de) 1993-08-25
CH675070A5 (pt) 1990-08-31
LU87208A1 (fr) 1988-12-13
KR880013551A (ko) 1988-12-21
NL8801185A (nl) 1988-12-01
ES2006649A6 (es) 1989-05-01
GR1000303B (el) 1992-05-12

Similar Documents

Publication Publication Date Title
ZA883239B (en) A multi-layer pharmaceutical composition
GB2204792B (en) Pharmaceutical composition
ZA883167B (en) Pharmaceutical composition
ZA895838B (en) Pharmaceutical compounds
AU101932S (en) A pharmaceutical tablet
ZA89260B (en) Pharmaceutical compounds
GB8825892D0 (en) Pharmaceutical composition
IL87943A (en) Pharmaceutical compositions containing a piperidinoalkanol-decongestant combination
IE872126L (en) Pharmaceutical compounds
GB8711408D0 (en) Pharmaceutical compound
GB8830078D0 (en) Pharmaceutical compounds
GB8826204D0 (en) Pharmaceutical compounds
GB8705900D0 (en) Pharmaceutical composition
GB8718907D0 (en) Pharmaceutical composition
GB8725648D0 (en) Pharmaceutical composition
ZA881474B (en) Pharmaceutical composition
GB8725055D0 (en) Pharmaceutical composition
ZA883400B (en) Pharmaceutical composition
GB8720401D0 (en) Pharmaceutical composition
GB8707739D0 (en) Pharmaceutical composition
GB8708041D0 (en) Pharmaceutical composition
GB8716574D0 (en) Pharmaceutical composition
IE872168L (en) Pharmaceutical composition
IE872788L (en) Pharmaceutical combination
IE870641L (en) Pharmaceutical combinations